Get startedLog in
    Picture of Hansa Biopharma AB logo

    HNSA — Hansa Biopharma AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapMomentum Trap
    All News

    Brief: Hansa Biopharma Gets Reimbursement For Idefirix In Czech Republic

    Picture of Hansa Biopharma AB logoHansa Biopharma AB
    02/01/2023 07:11
    Jan 2 (Reuters) - Hansa Biopharma AB  HNSA.ST :
    * HANSA BIOPHARMA ANNOUNCES POSITIVE REIMBURSEMENT DECISION
FOR
IDEFIRIX ®  (IMLIFIDASE) IN THE CZECH REPUBLIC
    * AVAILABILITY OF IDEFIRIX(®) FOR ELIGIBLE HIGHLY SENSITIZED
PATIENTS TO BEGIN JANUARY 1, 2023

Source text for Eikon:  ID:nWkr7s5gVW 
Further company coverage:  HNSA.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Hansa Biopharma AB

    See all news